scholarly journals Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events. [Corrigendum]

2013 ◽  
pp. 129
Author(s):  
Toyoaki Tsumura ◽  
Hirotaka Suzumura ◽  
Keiji Yoshikawa ◽  
Kimura ◽  
Sasaki ◽  
...  
Keyword(s):  
Intraocular Pressure ◽  
Adverse Events ◽  
Ophthalmic Solution ◽  
Normal Tension Glaucoma

scholarly journals Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events

2012 ◽  
pp. 1547 ◽  
Author(s):  
Toyoaki Tsumura ◽  
Hirotaka Suzumura ◽  
Keiji Yoshikawa ◽  
Kimura ◽  
Sasaki ◽  
...  
Keyword(s):  
Intraocular Pressure ◽  
Adverse Events ◽  
Ophthalmic Solution ◽  
Normal Tension Glaucoma

scholarly journals Bimatoprost ophthalmic solution 0.03% lowered intraocularpressure of normal-tension glaucoma with minimal adverse events [Corrigendum]

2013 ◽  
pp. 1363
Author(s):  
Toyoaki Tsumura ◽  
Hirotaka Suzumura ◽  
Keiji Yoshikawa ◽  
Kimura ◽  
Sasaki ◽  
...  
Keyword(s):  
Adverse Events ◽  
Ophthalmic Solution ◽  
Normal Tension Glaucoma

scholarly journals Sustainability of Intraocular Pressure Reduction of Travoprost Ophthalmic Solution in Subjects with Normal Tension Glaucoma

2016 ◽  
Vol 33 (3) ◽  
pp. 435-446 ◽  
Author(s):  
Tomoko Naito ◽  
Shinichi Okuma ◽  
Mikio Nagayama ◽  
Shiro Mizoue ◽  
Mineo Ozaki ◽  
...  
Keyword(s):  
Intraocular Pressure ◽  
Ophthalmic Solution ◽  
Normal Tension Glaucoma ◽  
Pressure Reduction ◽  
Intraocular Pressure Reduction

scholarly journals Travoprost with sofZia® preservative system lowered intraocular pressure of Japanese normal tension glaucoma with minimal side effects

2014 ◽  
pp. 347 ◽  
Author(s):  
Shiro Mizoue ◽  
Tadashi Nakano ◽  
Nobuo Fuse ◽  
Aiko Iwase ◽  
Shun Mastumoto ◽  
...  
Keyword(s):  
Intraocular Pressure ◽  
Side Effects ◽  
Normal Tension Glaucoma

Intraocular pressure measured by dynamic contour tonometer and ocular response analyzer in normal tension glaucoma

2009 ◽  
Vol 248 (1) ◽  
pp. 73-77 ◽  
Author(s):  
Tetsuya Morita ◽  
Nobuyuki Shoji ◽  
Kazutaka Kamiya ◽  
Mana Hagishima ◽  
Fusako Fujimura ◽  
...  
Keyword(s):  
Intraocular Pressure ◽  
Normal Tension Glaucoma ◽  
Ocular Response Analyzer ◽  
Dynamic Contour Tonometer

scholarly journals Surgery for normal tension glaucoma. Target intraocular pressure and visual field progression

2009 ◽  
Vol 75 (S224) ◽  
pp. 43-44 ◽  
Author(s):  
L. Fontana ◽  
A. C. Viswanathan ◽  
D. Poinooswamy ◽  
R. A. Hitchings ◽  
L. Scullica
Keyword(s):  
Intraocular Pressure ◽  
Visual Field ◽  
Normal Tension Glaucoma ◽  
Visual Field Progression

Incidence of Intraocular Pressure Spike and Other Adverse Events after Vitreoretinal Surgery

Ophthalmology ◽  
2006 ◽  
Vol 113 (1) ◽  
pp. 42-47 ◽  
Author(s):  
Nicholas G. Anderson ◽  
Mitchell S. Fineman ◽  
Gary C. Brown
Keyword(s):  
Intraocular Pressure ◽  
Adverse Events ◽  
Vitreoretinal Surgery ◽  
Pressure Spike

scholarly journals Effect of Desonide 0.25% Ophthalmic Solution on Central Corneal Thickness and Intraocular Pressure of Patients with Allergic Conjunctivitis

1970 ◽  
Vol 12 (3) ◽  
pp. 156-158
Author(s):  
Ozlem Gurses Sahin
Keyword(s):  
Intraocular Pressure ◽  
Allergic Conjunctivitis ◽  
Central Corneal Thickness ◽  
Corneal Thickness ◽  
Ophthalmic Solution ◽  
Applanation Tonometry ◽  
Goldmann Applanation Tonometry ◽  
Mean Values ◽  
Conjunctival Hyperaemia ◽  
Significant Difference

Aim: To evaluate whether a significant difference exists between the initial and final mean central corneal thickness that might affect Goldmann applanation tonometer recordings of patients with allergic conjunctivitis treated with desonide 0.25% ophthalmic solution, and to determine the effect of desonide on intraocular pressure by using adjusted intraocular pressure values.Methods: This double-blind randomised placebo-controlled trial enrolled 30 patients (60 eyes) with allergic conjunctivitis. Patients were randomly assigned to receive desonide to 1 eye (study eye) and preservative-free tear supplement (Tears Naturale Free®) to the other eye (control eye) 3 times daily for 3 weeks. Goldmann applanation tonometry and central corneal thickness of both eyes were recorded on the day of presentation and 3 weeks later.Results: Regression of itching, tearing, conjunctival hyperaemia, and tarsal conjunctival papillary reaction were noted in the study eyes after 3 weeks of treatment. The control eyes showed mild regression of pruritis, tearing, conjunctival hyperaemia, and tarsal conjunctival papillary reaction after 3 weeks. There was a significant difference between the initial and final mean central corneal thickness values for the study eyes (p = 0.003). There were no statistically significant differences between the initial and final mean values of Goldmann applanation tonometry and adjusted intraocular pressure for the study eyes. No statistically significant differences were found between the initial and final mean values of any of the parameters for the control eyes.Conclusion: Inflammation-induced increase in central corneal thickness of patients with allergic conjunctivitis treated with desonide showed statistically significant regression. However, this regression did not significantly affect Goldmann applanation tonometry and adjusted intraocular pressure values of the treated eyes.

Sign in / Sign up

Export Citation Format

Share Document